Singapore markets close in 5 hours 6 minutes

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4605-0.0086 (-1.83%)
At close: 04:00PM EDT
0.4753 +0.01 (+3.21%)
After hours: 06:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.49M
Enterprise value 334.60k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.93
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.50

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-76.72%
S&P500 52-week change 324.16%
52-week high 32.2100
52-week low 30.4390
50-day moving average 30.5508
200-day moving average 30.9015

Share statistics

Avg vol (3-month) 3139.6k
Avg vol (10-day) 364.97k
Shares outstanding 57.59M
Implied shares outstanding 67.59M
Float 87.41M
% held by insiders 12.30%
% held by institutions 14.21%
Shares short (28 Jun 2024) 4275.51k
Short ratio (28 Jun 2024) 41.95
Short % of float (28 Jun 2024) 43.72%
Short % of shares outstanding (28 Jun 2024) 43.63%
Shares short (prior month 31 May 2024) 4193.16k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 331 Mar 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-602.82%

Management effectiveness

Return on assets (ttm)-139.06%
Return on equity (ttm)-706.87%

Income statement

Revenue (ttm)1.75M
Revenue per share (ttm)0.51
Quarterly revenue growth (yoy)-61.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)-11.55M
Diluted EPS (ttm)-3.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.4M
Total cash per share (mrq)0.45
Total debt (mrq)245.97k
Total debt/equity (mrq)7.19%
Current ratio (mrq)2.87
Book value per share (mrq)0.51

Cash flow statement

Operating cash flow (ttm)-10.58M
Levered free cash flow (ttm)-6.86M